Avadel Pharmaceuticals (AVDL)
(Delayed Data from NSDQ)
$16.60 USD
+0.16 (0.97%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $16.61 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum D VGM
Price, Consensus and EPS Surprise
AVDL 16.60 +0.16(0.97%)
Will AVDL be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AVDL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AVDL
Harrow (HROW) Soars 12.9%: Is Further Upside Left in the Stock?
Wall Street Analysts Predict a 28.58% Upside in Avadel (AVDL): Here's What You Should Know
AVDL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why You Should Invest in Avadel (AVDL) Stock Now
Avadel (AVDL) is a Great Momentum Stock: Should You Buy?
How Much Upside is Left in Avadel (AVDL)? Wall Street Analysts Think 37.36%
Other News for AVDL
Avadel Pharmaceuticals to Join Russell 3000® Index
Avadel Pharmaceuticals Joins the Russell 3000® Index
Avadel Pharmaceuticals to join Russell 3000 index
Avadel Pharmaceuticals to join Russell 3000 Index
Jazz Pharmaceuticals: Pipeline Setback While Business Transition Continues